FLGT Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (FLGT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $41.8K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Xie Jian | President and COO | Sell | 2,127 | $19.66 | $41.8K | 359,924 −0.6% of holding | |
| Gao Hanlin | Chief Scientific Officer | Sell | 1,673 | $19.66 | $32.9K | 986,117 −0.2% of holding | |
| Xie Jian | President and COO | Sell | 1,193 | $19.91 | $23.7K | 362,051 −0.3% of holding | |
| Gao Hanlin | Chief Scientific Officer | Sell | 939 | $19.91 | $18.7K | 987,790 −0.1% of holding | |
| Xie Jian | President and COO | Sell | 2,146 | $17.89 | $38.4K | 367,605 −0.6% of holding | |
| Gao Hanlin | Chief Scientific Officer | Sell | 1,688 | $17.89 | $30.2K | 990,374 −0.2% of holding | |
| Xie Jian | President and COO | Sell | 1,201 | $17.60 | $21.1K | 369,751 −0.3% of holding | |
| Gao Hanlin | Chief Scientific Officer | Sell | 945 | $17.60 | $16.6K | 992,062 −0.1% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.